Trial intelligence / Profile preview

Medical Treatment Prior to ICSI in Endometriosis

NCT06577974Recruiting

Sponsor
Cairo University
Start
Jul 2024
Primary completion
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of drospirenone and dienogest (3 arms), sponsored by Cairo University. Primary endpoint: Fertilisation rate. Started Jul 2024; status: recruiting.

02

Drugs

drospirenonedienogest

Beyond the preview

Go deeper on NCT06577974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06577974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call